Handelsinvest Investeringsforvaltning Sells 642 Shares of Molina Healthcare, Inc. (NYSE:MOH)

Handelsinvest Investeringsforvaltning reduced its position in Molina Healthcare, Inc. (NYSE:MOH) by 34.2% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 1,237 shares of the company’s stock after selling 642 shares during the period. Handelsinvest Investeringsforvaltning’s holdings in Molina Healthcare were worth $508,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. McIlrath & Eck LLC bought a new stake in shares of Molina Healthcare in the fourth quarter valued at approximately $34,000. VisionPoint Advisory Group LLC lifted its position in shares of Molina Healthcare by 105.6% during the third quarter. VisionPoint Advisory Group LLC now owns 111 shares of the company’s stock worth $36,000 after acquiring an additional 57 shares in the last quarter. Principal Securities Inc. purchased a new stake in shares of Molina Healthcare during the fourth quarter worth $42,000. Friedenthal Financial purchased a new position in shares of Molina Healthcare in the fourth quarter valued at $43,000. Finally, Householder Group Estate & Retirement Specialist LLC grew its position in shares of Molina Healthcare by 3,933.3% in the fourth quarter. Householder Group Estate & Retirement Specialist LLC now owns 121 shares of the company’s stock valued at $43,000 after purchasing an additional 118 shares in the last quarter. 98.50% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

MOH has been the subject of several analyst reports. Bank of America downgraded Molina Healthcare from a “neutral” rating to an “underperform” rating and set a $439.00 target price for the company. in a research note on Thursday, March 28th. JPMorgan Chase & Co. cut their price objective on shares of Molina Healthcare from $435.00 to $420.00 and set an “overweight” rating for the company in a research report on Thursday, May 30th. Baird R W upgraded shares of Molina Healthcare to a “strong-buy” rating in a research note on Thursday, May 30th. Wells Fargo & Company reduced their price target on shares of Molina Healthcare from $410.00 to $375.00 and set an “equal weight” rating for the company in a research report on Monday, April 29th. Finally, Barclays decreased their price target on shares of Molina Healthcare from $437.00 to $430.00 and set an “equal weight” rating on the stock in a report on Thursday, April 25th. One research analyst has rated the stock with a sell rating, four have given a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $407.45.

Molina Healthcare Trading Up 0.1 %

Shares of MOH stock opened at $292.31 on Wednesday. The business has a 50-day moving average price of $325.40 and a two-hundred day moving average price of $361.87. Molina Healthcare, Inc. has a 12-month low of $288.79 and a 12-month high of $423.92. The company has a quick ratio of 1.49, a current ratio of 1.49 and a debt-to-equity ratio of 0.53. The firm has a market cap of $17.13 billion, a P/E ratio of 15.84, a price-to-earnings-growth ratio of 0.91 and a beta of 0.58.

Molina Healthcare (NYSE:MOH) last released its earnings results on Wednesday, April 24th. The company reported $5.73 earnings per share for the quarter, topping analysts’ consensus estimates of $5.46 by $0.27. Molina Healthcare had a return on equity of 29.86% and a net margin of 2.99%. The company had revenue of $9.93 billion during the quarter, compared to the consensus estimate of $9.45 billion. During the same quarter in the previous year, the company posted $5.81 EPS. Molina Healthcare’s quarterly revenue was up 21.9% compared to the same quarter last year. Equities analysts anticipate that Molina Healthcare, Inc. will post 23.56 EPS for the current fiscal year.

Insider Activity

In related news, Director Ronna Romney sold 250 shares of the stock in a transaction dated Tuesday, May 21st. The stock was sold at an average price of $343.27, for a total transaction of $85,817.50. Following the completion of the sale, the director now directly owns 16,945 shares in the company, valued at approximately $5,816,710.15. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other news, Director Ronna Romney sold 250 shares of the stock in a transaction dated Tuesday, May 21st. The shares were sold at an average price of $343.27, for a total transaction of $85,817.50. Following the completion of the sale, the director now directly owns 16,945 shares in the company, valued at $5,816,710.15. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, COO James Woys sold 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 22nd. The shares were sold at an average price of $345.15, for a total value of $3,451,500.00. Following the transaction, the chief operating officer now directly owns 53,613 shares in the company, valued at $18,504,526.95. The disclosure for this sale can be found here. 1.11% of the stock is owned by corporate insiders.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.